Amalgamated Bank Biotechnology

Amalgamated Bank

$13.6 Billion
Q3 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ABSI Absci Corp	$305M	$8,000 0.0% of portfolio	2,763	Q2 2024 New
PBYI Puma Biotechnology, Inc.	$231M	$7,000 0.0% of portfolio	1,432	Q2 2024 New
ENTA Enanta Pharmaceuticals Inc	$239M	$7,000 0.0% of portfolio	667	Q1 2024 Reduced 64.43%
SCPH Sc Pharmaceuticals Inc.	$155M	$7,000 0.0% of portfolio	1,358	Q1 2025 Added 39.57%
FENC Fennec Pharmaceuticals Inc.	$206M	$7,000 0.0% of portfolio	821	Q1 2025 Added 34.15%
ALEC Alector, Inc.	$108M	$7,000 0.0% of portfolio	2,540	Q2 2024 Added 16.57%
AVIR Atea Pharmaceuticals, Inc.	$277M	$7,000 0.0% of portfolio	2,673	Q1 2024 Reduced 60.55%
ABEO Abeona Therapeutics Inc.	$24.8M	$7,000 0.0% of portfolio	1,492	Q2 2025 New
CDXS Codexis, Inc.	$115M	$6,000 0.0% of portfolio	2,780	Q1 2025 Added 33.4%
VYGR Voyager Therapeutics, Inc.	$164M	$6,000 0.0% of portfolio	1,382	Q2 2024 Added 29.04%
DMAC Dia Medica Therapeutics Inc.	$169M	$6,000 0.0% of portfolio	902	Q2 2025 New
HRTX Heron Therapeutics, Inc.	$135M	$5,000 0.0% of portfolio	4,047	Q1 2025 Added 12.29%
CHRS Coherus Bio Sciences, Inc.	$97.9M	$5,000 0.0% of portfolio	3,609	Q2 2024 Added 39.88%
ALLO Allogene Therapeutics, Inc.	$170M	$5,000 0.0% of portfolio	4,430	Q1 2025 Added 60.16%
HUMA Humacyte, Inc.	$133M	$5,000 0.0% of portfolio	3,034	Q1 2025 Added 39.88%
QSI Quantum Si Inc	$188M	$5,000 0.0% of portfolio	4,142	Q1 2025 Added 30.66%
PLX Protalix Bio Therapeutics, Inc.	$106M	$5,000 0.0% of portfolio	2,381	Q2 2025 New
CADL Candel Therapeutics, Inc.	$145M	$5,000 0.0% of portfolio	980	Q1 2025 Added 42.86%
LIFE A Tyr Pharma Inc	$53.2M	$5,000 0.0% of portfolio	2,971	Q2 2025 New
SLS Sellas Life Sciences Group, Inc.	$31M	$5,000 0.0% of portfolio	3,259	Q2 2025 New
ELDN Eledon Pharmaceuticals, Inc.	$29.3M	$5,000 0.0% of portfolio	2,002	Q2 2025 New
TARA Protara Therapeutics, Inc.	$60.4M	$4,000 0.0% of portfolio	1,103	Q2 2025 New
CRDF Cardiff Oncology, Inc.	$99.2M	$4,000 0.0% of portfolio	2,009	Q1 2025 Added 48.27%
TRDA Entrada Therapeutics, Inc.	$242M	$4,000 0.0% of portfolio	852	Q1 2025 Added 18.17%
LRMR Larimar Therapeutics, Inc.	$157M	$4,000 0.0% of portfolio	1,452	Q1 2025 Added 67.86%
FATE Fate Therapeutics Inc	$106M	$3,000 0.0% of portfolio	2,912	Q1 2024 Reduced 60.9%
NKTX Nkarta, Inc.	$95.9M	$3,000 0.0% of portfolio	1,826	Q1 2025 Added 62.31%
FHTX Foghorn Therapeutics Inc.	$184M	$3,000 0.0% of portfolio	681	Q1 2024 Reduced 76.3%
THRD Third Harmonic Bio, Inc.	$217M	$3,000 0.0% of portfolio	665	Q1 2024 Reduced 72.31%
GLSI Greenwich Life Sciences, Inc.	$109M	$2,000 0.0% of portfolio	207	Q2 2024 New
NVCT Nuvectis Pharma, Inc.	$89.9M	$2,000 0.0% of portfolio	440	Q2 2025 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	1,682	Q3 2024 Added 105.62%
INMB Inmune Bio, Inc.	$27.1M	$0 0.0% of portfolio	422	Q2 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.